Celgene thinks over the bid for Human Genome Sciences
There are two companies apart from Glaxo that are in the process of discussion to make a bid for Human Genome according to reports from sources who are familiar with the situation.
There are two companies apart from Glaxo that are in the process of discussion to make a bid for Human Genome according to reports from sources who are familiar with the situation.